Studies related to Colorectal Cancer Risk and Curcumin

Phase IIa Clinical Trial Of Curcumin For The Prevention Of Colorectal Neoplasia

Effect Decrease
Trial Design Non-controlled trial
Trial Length n/a
Number of Subjects 44
Sex n/a
Notes for this study:
In a non-randomized open label study, 2g and 4g of curcumin over the period of 30 days was able to reduce the amount of aberrant crypt foci in colorectal tissue only at the 4g dosage.

Patients were those with already present aberrant crypt foci and smokers, and without the usage of other anti-inflammatories.

Full details on all 2 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.